PMGC Holdings Inc. (NASDAQ:ELAB) Short Interest Update

PMGC Holdings Inc. (NASDAQ:ELAB) was the recipient of a large decline in short interest in the month of January. As of January 30th, there was short interest totaling 30,685 shares, a decline of 21.4% from the January 15th total of 39,049 shares. Based on an average daily volume of 224,327 shares, the short-interest ratio is presently 0.1 days. Currently, 6.1% of the shares of the company are short sold. Currently, 6.1% of the shares of the company are short sold. Based on an average daily volume of 224,327 shares, the short-interest ratio is presently 0.1 days.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on the company. Wall Street Zen raised PMGC to a “sell” rating in a research report on Saturday, October 25th. Weiss Ratings restated a “sell (e+)” rating on shares of PMGC in a research report on Monday, December 29th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company currently has an average rating of “Sell”.

PMGC Stock Down 2.1%

Shares of ELAB traded down $0.03 during midday trading on Monday, hitting $1.37. The company’s stock had a trading volume of 463,728 shares, compared to its average volume of 2,366,472. PMGC has a one year low of $1.33 and a one year high of $171.50. The stock has a market capitalization of $685,000.00, a price-to-earnings ratio of -0.02 and a beta of 0.70. The company’s fifty day simple moving average is $6.07 and its two-hundred day simple moving average is $17.22.

PMGC (NASDAQ:ELAB) last released its quarterly earnings data on Friday, November 14th. The company reported ($19.80) earnings per share for the quarter. The company had revenue of $0.29 million during the quarter.

About PMGC

Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021. Elevai Labs, Inc was incorporated in 2020 and is based in Newport Beach, California.